Despite the differences observed, the convergence of data denotes a potential dysregulation in blood CD4+ T cells in our cohort of patients and the decrease in the frequency could be attributed to the inability of these cells to mount appropriate immune response and/or having an exhaustive phenotype in COPD with disease progression. The gene discussed is CD4; the disease is chronic obstructive pulmonary disease.